Science Explorer Back to mapMap
Discussion
Researcher · General Hospital Ernakulam · India

Jasvin Kurundrayil Manha

Jasvin Kurundrayil Manha publishes mostly in Endocrinology, Diabetes and Metabolism, Oncology and Hematology, on topics such as CAR-T cell therapy research, Diabetes Treatment and Management and Drug-Induced Hepatotoxicity and Protection.

OpenAlex
World rank
#5,341,702
of 7,710,434 ranked researchers
Rank in India
#152,934
of 280,097
Works
16
Citations
2
Citations per work
0.1
h-index
1
i10-index 0Top 99.6% in Endocrinology, Diabetes and Metabolism
Jasvin Kurundrayil Manha

What does Jasvin Kurundrayil Manha research?

Jasvin Kurundrayil Manha's work is mostly in Medicine (74%), Pharmacology, Toxicology and Pharmaceutics (6%).

Health Sciences: 12 works · 74.4% of their workMedicine: 12 works · 74.4% of their workEndocrinology, Diabetes and Metabolism: 4 works · 22.9% of their workOncology: 4 works · 22.9% of their workHematology: 2 works · 11.4% of their workEpidemiology: 1 works · 8.6% of their workPulmonary and Respiratory Medicine: 1 works · 8.6% of their workEverything else: 3 works · 19.9% of their workLife Sciences: 1 works · 5.7% of their workPharmacology, Toxicology and Pharmaceutics: 1 works · 5.7% of their workPharmacology: 1 works · 5.7% of their workTHEIR WORKJasvinKurundrayil Manha16works
Life Sciences6%Health Sciences74%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine1274.4%
  2. Everything else319.9%
    1. Pharmacology, Toxicology and Pharmaceutics15.7%
  1. 1Endocrinology, Diabetes and Metabolism23% of their works
  2. 2Oncology23% of their works
  3. 3Hematology11% of their works
  4. 4Epidemiology9% of their works
  5. 5Pulmonary and Respiratory Medicine9% of their works
  6. 6Pharmacology6% of their works

Research topics

Which keywords describe Jasvin Kurundrayil Manha's research?

The keywords of their largest research topics: CAR T Cells, Chimeric Antigen Receptor, Heart Failure, Cardiovascular Outcomes, Insulin Resistance, Metabolic Syndrome, Type 2 Diabetes and Cardiovascular Disease.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. CAR T Cells61 topic
  2. Chimeric Antigen Receptor61 topic
  3. Heart Failure52 topics
  4. Cardiovascular Outcomes41 topic
  5. Insulin Resistance42 topics
  6. Metabolic Syndrome42 topics
  7. Type 2 Diabetes41 topic
  8. Cardiovascular Disease32 topics
  9. Diabetes21 topic
  10. Diagnosis Criteria21 topic
  11. Drug-Induced Liver Injury21 topic
  12. Hepatotoxicity21 topic
  13. International Myeloma Working Group21 topic
  14. NAFLD21 topic
  15. NASH21 topic
  16. Obesity21 topic
  17. Diagnosis11 topic
  18. Guidelines11 topic
  19. Ion Channels11 topic
  20. Voltage-Gated Channels11 topic

Where does Jasvin Kurundrayil Manha work?

Jasvin Kurundrayil Manha's main affiliation in the publication record is General Hospital Ernakulam, India.

How many publications and citations does Jasvin Kurundrayil Manha have?

OpenAlex counts 16 works and 2 citations for Jasvin Kurundrayil Manha, an h-index of 1, ranking #5,341,702 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Jasvin Kurundrayil Manha. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.